RecruitingNCT07374107

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) - A Qualitative Study of Patient-voiced Research Priorities Across Rare Myositis Diseases


Sponsor

Myositis International Health & Research Collaborative Alliance Foundation

Enrollment

700 participants

Start Date

Jun 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing research concerns as identified by patients. Findings will be analyzed to create a patient-voiced set of research priorities that can guide the direction of research and help inform funding decisions across myositis diseases. Potential participants can express interest via https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/


Eligibility

Min Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No intervention - qualitative and mixed methods investigations for people with anti-synthetase syndrome, dermatomyositis, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention - qualitative and mixed methods investigations

No Intervention


Locations(1)

MIHRA Foundation - This is a GLOBAL STUDY

New Orleans, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07374107


Related Trials